| P50 | author | Guillaume J Pegna | Q87146186 |
| P2093 | author name string | Juli R Bagó | |
| | Shawn D Hingtgen | |
| | Onyi Okolie | |
| P2860 | cites work | A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants | Q39285646 |
| | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. | Q39744489 |
| | Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres. | Q40204007 |
| | Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors. | Q40552522 |
| | Permeability of three-dimensional fibrin constructs corresponds to fibrinogen and thrombin concentrations | Q41991946 |
| | The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma | Q42809291 |
| | Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 |
| | Bioluminescence imaging of cardiomyogenic and vascular differentiation of cardiac and subcutaneous adipose tissue-derived progenitor cells in fibrin patches in a myocardium infarct model | Q44209749 |
| | Effect of scaffold dilution on migration of mesenchymal stem cells from fibrin hydrogels | Q44957279 |
| | Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. | Q45798961 |
| | Fibrin sealant for control of cerebrospinal fluid otorrhea. | Q47874878 |
| | Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds | Q48910075 |
| | Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. | Q52305456 |
| | Measuring chemotaxis and chemokinesis: the under-agarose cell migration assay | Q73014461 |
| | Three-dimensional cell culturing by magnetic levitation | Q85752448 |
| | Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases | Q21133553 |
| | Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo | Q27336125 |
| | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 |
| | CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. | Q30373363 |
| | The hard life of soft cells | Q30480676 |
| | The role of interstitial BCNU chemotherapy in the treatment of malignant glioma | Q33954751 |
| | The use of neural stem cells in cancer gene therapy: predicting the path to the clinic | Q34217778 |
| | Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response | Q34243638 |
| | A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy | Q34341900 |
| | Fibrin sealants in surgical practice: An overview | Q34376135 |
| | Fibrin glue as a drug delivery system | Q34422490 |
| | Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases | Q34599885 |
| | Use of Tisseel Fibrin Sealant in Neurosurgical Procedures: Incidence of Cerebrospinal Fluid Leaks and Cost-Benefit Analysis in a Retrospective Study | Q35109169 |
| | Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts | Q35175677 |
| | A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma | Q35256949 |
| | Fibrinogen and fibrin. | Q36101288 |
| | Real-time multi-modality imaging of glioblastoma tumor resection and recurrence. | Q36543537 |
| | Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas | Q36695971 |
| | Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors | Q36913828 |
| | Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 |
| | Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy | Q37140126 |
| | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide | Q37356520 |
| | Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies | Q37396577 |
| | Glioblastoma multiforme: a review of where we have been and where we are going | Q37530934 |
| | Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone | Q37879267 |
| | Targeting TRAIL in the treatment of cancer: new developments. | Q38500801 |
| | Fibrin matrices: The versatile therapeutic delivery systems. | Q38558502 |
| | Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: implications for cell-based therapy. | Q39140400 |
| | Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy | Q39245228 |
| P304 | page(s) | 42-53 | |
| P577 | publication date | 2016-01-06 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer | |
| P478 | volume | 84 | |